BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29532200)

  • 21. Ovarian response after random-start controlled ovarian stimulation to cryopreserve oocytes in cancer patients.
    Campos APC; Geber GP; Hurtado R; Sampaio M; Geber S
    JBRA Assist Reprod; 2018 Nov; 22(4):352-354. PubMed ID: 30264947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The medical and ethical challenges of fertility preservation in teenage girls: a case series of sickle cell anaemia patients prior to bone marrow transplant.
    Lavery SA; Islam R; Hunt J; Carby A; Anderson RA
    Hum Reprod; 2016 Jul; 31(7):1501-7. PubMed ID: 27112701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fertility Preservation Decisions Among Newly Diagnosed Oncology Patients: A Single-Center Experience.
    Nurudeen SK; Douglas NC; Mahany EL; Sauer MV; Choi JM
    Am J Clin Oncol; 2016 Apr; 39(2):154-9. PubMed ID: 24441581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers.
    Leader B; Hegde A; Baca Q; Stone K; Lannon B; Seifer DB; Broekmans F; Baker VL
    Fertil Steril; 2012 Oct; 98(4):1037-42. PubMed ID: 22771028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation.
    Cakmak H; Katz A; Cedars MI; Rosen MP
    Fertil Steril; 2013 Dec; 100(6):1673-80. PubMed ID: 23987516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
    Vuong TN; Ho MT; Ha TD; Phung HT; Huynh GB; Humaidan P
    Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age.
    Liao CC; Lee RK; Lin SY; Lin MH; Hwu YM
    Taiwan J Obstet Gynecol; 2016 Apr; 55(2):239-43. PubMed ID: 27125408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controls.
    Decanter C; Robin G; Mailliez A; Sigala J; Morschhauser F; Ramdane N; Devos P; Dewailly D; Leroy-Martin B; Keller L
    Reprod Biomed Online; 2018 May; 36(5):543-551. PubMed ID: 29506861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oocyte accumulation for fertility preservation in women with benign ovarian tumours with a history of previous surgery, multiple or large cysts.
    Legrand C; Keller L; Collinet P; Barbotin AL; Béhal H; Rubod C; Decanter C
    Reprod Biomed Online; 2021 Aug; 43(2):205-214. PubMed ID: 34247989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian stimulation in the luteal phase: systematic review and meta-analysis.
    Boots CE; Meister M; Cooper AR; Hardi A; Jungheim ES
    J Assist Reprod Genet; 2016 Aug; 33(8):971-80. PubMed ID: 27146151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield.
    Hourvitz A; Yerushalmi GM; Maman E; Raanani H; Elizur S; Brengauz M; Orvieto R; Dor J; Meirow D
    Reprod Biomed Online; 2015 Oct; 31(4):497-505. PubMed ID: 26278808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled ovarian stimulation outcomes of fertility preservation procedures in newly diagnosed breast cancer patients: a retrospective study from a single-tertiary-IVF centre.
    Sahin G; Goker ENT; Gokmen E; Yeniay L; Acet F; Zekioglu O; Tavmergen E
    J Obstet Gynaecol; 2022 Apr; 42(3):518-523. PubMed ID: 34382483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oocyte cryopreservation for fertility preservation in women with ovarian endometriosis.
    Kim SJ; Kim SK; Lee JR; Suh CS; Kim SH
    Reprod Biomed Online; 2020 Jun; 40(6):827-834. PubMed ID: 32295746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fertility preservation in women with malignancies: the accuracy of antral follicle count collected randomly during the menstrual cycle in predicting the number of oocytes retrieved.
    Filippi F; Martinelli F; Paffoni A; Reschini M; Raspagliesi F; Somigliana E
    J Assist Reprod Genet; 2019 Mar; 36(3):569-578. PubMed ID: 30478807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
    Sonigo C; Simon C; Boubaya M; Benoit A; Sifer C; Sermondade N; Grynberg M
    Hum Reprod; 2016 Jul; 31(7):1493-500. PubMed ID: 27165625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Smoothing Gan Reinforcing Shen Method Adjuvantly Treated Poor Response of Diminished Ovari- an Reserve Patients in in vitro Fertilization and Embryo Transfer: a Clinical Study].
    Zhang Z; Zhang XH; He TY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Oct; 35(10):1170-4. PubMed ID: 26677665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
    von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
    Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of aromatase inhibitor on controlled ovarian stimulation for oocyte cryopreservation in adolescent and young cancer patients.
    Suzuki R; Horage-Okutsu Y; Kawahara T; Nakamura K; Shiraishi E; Iwahata H; Suzuki-Takahashi Y; Sugishita Y; Takae S; Suzuki N
    J Obstet Gynaecol Res; 2023 Mar; 49(3):973-979. PubMed ID: 36606606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Random-start controlled ovarian stimulation for emergency fertility preservation in a patient with myelodysplastic syndrome: a case report.
    Cai H; Shen H
    Braz J Med Biol Res; 2016; 49(6):e5227. PubMed ID: 27191608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-Müllerian hormone levels to predict oocyte maturity and embryo quality during controlled ovarian hyperstimulation.
    Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
    Minerva Ginecol; 2017 Jun; 69(3):225-232. PubMed ID: 27352270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.